ArticleClinical and translational medicine2026

TMEM92 shields DDX3X from TTC3-mediated degradation to confer chemoresistance in triple-negative breast cancer.

Hao Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.